Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid Injection for Adhesive Capsulitis
NCT04364425Unknown
- Sponsor
- Taipei Veterans General Hospital
- Start
- May 2020
- Primary completion
- Sep 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of triamcinolone acetonide in adhesive capsulitis (AC) (2 arms), sponsored by Taipei Veterans General Hospital. Primary endpoint: Change in Pain Intensity (Visual Analog Scale) at 12 weeks. Status: unknown.
02
Drugs
triamcinolone acetonide
03
Conditions
adhesive capsulitis (AC)
Beyond the preview
Go deeper on NCT04364425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04364425.